Calcium/Calmodulin Kinase Inhibitors and Immunosuppressant Macrolides Rapamycin and FK506 Inhibit Progestin- and Glucocorticosteroid Receptor-Mediated Transcription in Human Breast Cancer T47D Cells
The effects of immunosuppressants and inhibitors of specific calcium/calmodulin kinase (CaMK) of types II and IV on progestin/glucocorticosteroid-induced transcription were studied in two human stably transfected breast cancer T47D cell lines. The lines contain the chloramphenicol acetyl transferase...
Gespeichert in:
Veröffentlicht in: | Molecular endocrinology (Baltimore, Md.) Md.), 1998-07, Vol.12 (7), p.986-1001 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The effects of immunosuppressants and inhibitors
of specific calcium/calmodulin kinase (CaMK) of types II and IV on
progestin/glucocorticosteroid-induced transcription were studied in two
human stably transfected breast cancer T47D cell lines. The lines
contain the chloramphenicol acetyl transferase (CAT) gene under control
either of the mouse mammary tumor virus promoter (T47D-MMTV-CAT), or
the minimal promoter containing five glucocorticosteroid/progestin
hormone response elements [T47D-(GRE)5-CAT].
Progestin- and triamcinolone acetonide (TA)-induced CAT gene expression
was inhibited in a dose-dependent manner in both lines by preincubation
with rapamycin (Rap) and, to a lesser extent, with FK506, but not with
cyclosporin A. CaMK II and/or IV inhibitors KN62 and KN93 also
inhibited progestin- and TA-stimulated transcription in both lines.
None of these drugs had any effect on basal transcription. The
antagonist RU486 inhibited all the effects of both progestin and TA,
suggesting that progesterone receptor (PR)-, as well as
glucocorticosteroid receptor (GR)- mediated transactivation are targets
of immunosuppressants and CaMKs in T47D cells. Indeed, Northern
analysis showed that Rap, KN62, and, to a lesser degree, FK506
inhibited progestin stimulation of Cyclin D1 mRNA levels, but not those
of the non-steroid-regulated glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) gene. Addition of Rap or KN62 after exposure of cells to
progesterone agonist Org 2058 had no effect on induction of CAT
activity. Taken together, these data indicate that Rap and FK506, as
well as CaMK inhibitors, inhibit steroid-induced activities of
exogenous, as well as of some endogenous, steroid receptor-regulated
genes by a mechanism preceding hormone-induced receptor activation.
Rap appeared to stabilize a 9S form of[
3H]Org 2058-PR complexes isolated from T47D
(GRE)5CAT cell nuclei. By contrast, the
progesterone receptor (PR) was isolated from cells treated with KN62 as
a 5S entity, undistinguishable from the 5S PR species extracted from
cells treated with progestin only. The nuclear
9S-[3H]Org2058-PR resulting from cells
exposed to Rap, contained, in addition to the heat shock proteins of 90
kDa and 70 kDa (hsp90 and hsp70), the FK506-binding immunophilin FKBP52
but not FKBP51, although the latter was part of unliganded PR
heterocomplex associated with hsp90. These results suggest that Rap and
KN62 act upon the PR by distinct mechanisms, with only Rap impeding
progestin-induced PR tr |
---|---|
ISSN: | 0888-8809 1944-9917 |
DOI: | 10.1210/mend.12.7.0128 |